Skip to main content
PLOS One logoLink to PLOS One
. 2026 Apr 1;21(4):e0345923. doi: 10.1371/journal.pone.0345923

Chemical characterization, antimicrobial, and antioxidant potentials of Juniperus phoenicea wood tar

Sadia Tina 1,*, Oussama Khibech 2, Samy Iskandar 1, Mohamed Bouhrim 3, Mohammed Al-zharani 4,*, Fahd A Nasr 4, Ashraf Ahmed Qurtam 4, Allal Challioui 2, Balouch Lhousaine 1, Meryem El Jemli 1
Editor: Marcello Iriti5
PMCID: PMC13043053  PMID: 41920972

Abstract

Wood tar obtained from Juniperus phoenicea L. is traditionally used in Morocco, yet its chemical profile and biological activities remain insufficiently documented. In this work, Juniperus phoenicea wood tar (JPWT) was chemically characterized by GC-MS, qualitatively screened for major phytochemical classes, and evaluated for total polyphenols, tannins and flavonoids contents. Antioxidant activity was assessed using DPPH and FRAP assays, and antibacterial activity was screened by the disc diffusion method. GC-MS identified 17 compounds, with hydroxychavicol (46.3%), 2,3-dehydroferruginol (18.5%) and eugenol (7.3%) as major constituents. JPWT showed high levels of polyphenols (242.91 ± 68.93 µg GAE/mg), tannins (110.59 ± 11.31 µg TAE/mg) and flavonoids (26.74 ± 0.52 µg QE/mg). JPWT exhibited antioxidant activity with an IC50 of 17.05 ± 0.67 µg/mL in the DPPH assay and an EC50 of 75.81 ± 2.02 µg/mL in the FRAP assay, confirming its antioxidant activity. Antibacterial screening revealed dose-dependent inhibition, with stronger effects against Gram-positive strains. Molecular docking suggested that hydroxychavicol and 2,3-dehydroferruginol may contribute to antibacterial activity through favorable binding to MRSA PBP2a and ESBL CTX‑M‑15. Overall, these findings support JPWT as a promising natural source of antimicrobial and antioxidant agents and warrant further isolation and in vivo investigations.

1. Introduction

The Mediterranean basin is a globally recognized biodiversity hotspot and a major reservoir of aromatic and medicinal plants estimated at approximately 25000–30000 species and subspecies [1]. It is in this large biodiversity hot-spot that the Iberian Peninsula and Morocco act as one of the two principal centers of plant diversity, with Turkey and Greece being the other [2]. With its Mediterranean climate, vast plains, and high mountain ranges rising to 4000 meters, diverse flora and variety are favorable for growing in Morocco. In recent years, natural products, especially medicinal plants, have attracted the scientific community as promising alternatives for treating various infectious diseases [3,4]. In this context, the antimicrobial and antioxidant properties of essential oils are well documented, leading to their application in pharmacology, medicine, microbiology, plant pathology, and food preservation [5,6]. However, the increasing emergence of multidrug-resistant microorganisms poses a serious global health challenge. The excessive use of antibiotics has significantly diminished their effectiveness, as demonstrated by the resistance observed in many bacteria notably Escherichia coli and Klebsiella pneumoniae [7]. Similarly, oxidative stress has emerged as a critical causative factor in aging and several chronic diseases such as diabetes, cancer, atherosclerosis, arthritis, and neurodegenerative disorders [8], All of which are often characterized by attendant inflammatory responses [9]. In response, plants produce variety of secondary metabolites including alkaloids, terpenoids, and phenolic compounds such as phenolic acids, flavonoids, tannins, lignins, quinones, and coumarins which are responsible for their antimicrobial, antioxidant, anti-inflammatory, and anticarcinogenic activities [10]. Juniperus phoenicea L. (JP) is a monoecious or dioecious coniferous tree or shrub belonging to the Cupressaceae family, characterized by its scaly leaves [11]. It plays a significant ecological role in the western Mediterranean basin, being considered a keystone species in cold-adapted open woodlands with steppe-like vegetation [12]. In addition to its ecological importance, JP has long been valued in traditional medicine for its hypoglycaemic, diuretic, antidiarrheal, antirheumatic, and broncho-pulmonary applications [13]. Among its derivatives, Juniperus phoenicea wood tar (JPWT), obtained by the destructive distillation of JP wood, is traditionally used for skin ailments and infections [14]. Such extraction methods remain largely unvalorized, with only a few studies devoted to them.

The present study aimed to qualitatively screen JPWT for major classes of secondary metabolites, to quantify total polyphenols, tannins and flavonoids, evaluate antioxidant activity by using DPPH and FRAP assays, evaluate antibacterial activity against selected Gram-positive and Gram-negative strains, and to use molecular docking as a complementary approach to explore potential molecular targets and provide mechanistic insights into the observed antibacterial activity.

2. Materials and methods

2.1. Plant materials

Wood of Juniperus phoenicea L. was collected from Termilat (Ifrane Province, Morocco; 33°30’02.1“N, 5°05’28.0”W). The plant material was taxonomically identified by Prof. Taleb Sghir. A voucher specimen (RAB114890) was deposited at the Herbarium of the Scientific Institute of Rabat (Morocco). Collected branches were examined for integrity and absence of dust and insect contamination. No specific permits or official authorizations were required for the collection of plant material, as the species is not protected and the sampling sites are not located in restricted areas. Plant collection was carried out in accordance with local practices and regulations. Particular care was taken to minimize environmental impact and preserve the surrounding ecosystem.

2.2. Preparation of plant extracts

The wood (100 g) is placed in a flask (250 mL) and heated to carbonization (1 h). The steam released during distillation is conducted through a pipe and condensed in a cold settling tank. One hour later, two distinct layers are formed: an upper layer, made up of a brownish-yellow aqueous liquid, corresponding to the phase not used in traditional Moroccan medicine, and a lower layer, corresponding to the tar, which is collected in an opaque glass bottle.

2.3. Qualitative phytochemical tests

JPWT was qualitatively screened for major classes of secondary metabolites (alkaloids, tannins, polyphenols, flavonoids and saponins) using standard colorimetric tests [15,16].

2.3.1. Alkaloids.

A total of 0.5 g of JPWT was mixed with 5 mL of 60% ethanol and then divided into two equal portions. The presence of alkaloids was confirmed by the formation of a reddish-brown precipitate after the addition of a few drops of Dragendorff’s reagent, or by the appearance of a white precipitate following the addition of Mayer’s reagent [15].

2.3.2. Test for tannins.

The addition of a few drops of a 5% ferric chloride solution to a mixture of the JPWT extract and 2 ml of ethanol showed the appearance of blue coloration, indicating the presence of tannins [15].

2.3.3. Saponins.

After adding 2 mL of distilled water to 2 mL of the ethanolic JPWT solution, the mixture was shaken for 1 minute. The formation of a persistent foam layer of approximately 1 cm after 15 min indicates the presence of saponins [17].

2.3.4. Test for flavonoids.

When 1 ml NaOH was mixed with 2 ml ethanolic extract of JPWT, the presence of flavonoid was revealed by the appearance of a yellow color [18].

2.3.5. Polyphenols.

The polyphenols were characterized by the reaction with ferric chloride (FeCl3). To 1 mL of methanolic extract, the addition of one drop of a 2% alcoholic ferric chloride solution resulting in a green coloration indicates the presence of polyphenols [19].

2.4. Total chemical quantification

2.4.1. Polyphenols.

Spectrophotometric analysis was performed using the Folin-Ciocalteu reagent, following a modified method previously described by [20]. 20 μL of each wood tar extract is mixed with 1.16 ml distilled water, 100 μL of Folin-Ciocalteu reagent and 300 μL of freshly prepared 20% sodium carbonate (Na2CO3). Absorbance against a blank was determined at 765nm after 30 minutes. The total phenolic content was expressed as micrograms of gallic acid equivalents per milligram of extract (μg GAE/mg).

2.4.2. Flavonoids.

A modified method based on the proposed by [21] was used. 0.5 mL of the extract was mixed with 0.5 mL aluminum chloride (AlCl3) and incubate at room temperature for 1 hour then its absorbance was measured against a blank at 420 nm. Total flavonoid content was expressed as micrograms of quercetin equivalents per milligram of extract (μg QE/mg).

2.4.3. Tannins.

The Folin and Ciocalteu methods were used to create standard curves for tannin [22]. 1.5 mL of 20% sodium carbonate and 0.5 mL of Folin-phenol reagent were combined with 6.9 mL of distilled water and 0.1 mL of the extracts. The mixture was shaken well and allowed to sit at room temperature for 1 h. The absorbance was measured at 725 nm in a spectrophotometer. Tannic acid (µg TAE/mg) is used to express the results of tannins.

2.5. Antioxidant activity

2.5.1. 2,2-Diphenyl-1-picrylhydrazylradical (DPPH) radical assay.

The DPPH radical scavenging activity of JPWT was determined according to the method described by Ouakil et al. [23]. Briefly, 2 mL of DPPH solution (0.02 mM in methanol) was mixed with 50 µL of JPWT solution prepared in methanol. The mixture was incubated for 30 min in the dark at room temperature, and absorbance was measured at 517 nm. A control was prepared using 2 mL of DPPH solution and 50 µL of methanol. The percentage of DPPH inhibition was calculated, and results were expressed as IC50 (µg/mL), defined as the concentration required to reduce the initial DPPH concentration by 50%. Tests were carried out in triplicate using ascorbic acid and butylated hydroxytoluene (BHT) as positive controls. Radical scavenging activity was expressed as percentage inhibition of DPPH radical and was calculated by following the equation:

% Inhibition=(Absorbance of control−Absorbance of samples)Absorbance of control*100

The antioxidant activity of wood cedar wood tar extracts was expressed as IC50, defined as the concentration of the test material required to cause a 50% decrease in initial DPPH concentration.

2.5.2. Ferric-reducing antioxidant power (FRAP) assay.

The ferric reducing antioxidant power (FRAP) of JPWT was evaluated according to Yen and Chen [24], with minor modifications. A 0.1% (w/v) solution of JPWT was prepared. Briefly, 1 mL of JPWT solution was mixed with 2.5 mL of phosphate buffer (0.2 M, pH 6.6) and 2.5 mL of potassium ferricyanide solution (1% w/v). The mixture was incubated at 50°C for 20 min, then 2.5 mL of trichloroacetic acid (10% w/v) was added. After centrifugation, 2.5 mL of the supernatant was mixed with 2.5 mL of distilled water and 0.5 mL of ferric chloride solution (0.1% w/v). Absorbance was measured at 700 nm. BHT was used as a positive control. The IC50 (µg/mL) value was calculated. All measurements were performed in triplicate.

2.6. Disc diffusion assay

The antibacterial activity of JPWT was tested against both gram-positive and Gram-negative bacteria at 25 mg/mL and 50 mg/mL by the disc diffusion method described by Kalemba and Kunicka [17], with minor modifications. The following bacterial strains were obtained at the Research Technology Platforms of Mohamed VI University of Sciences and Health: Staphylococcus aureus (methicillin-resistant, MRSA 6538), Staphylococcus aureus ATCC 6538, Enterococcus faecalis 29212CQ, Pseudomonas aeruginosa ATCC 27853, Escherichia coli (ESBL-EC) 2897K, Escherichia coli (CREC) 2878K, and Escherichia coli ATCC 1225. Each inoculum was adjusted to 1.106 CFU/mL (0.5 McFarland), and 0.5 mL of each suspension was spread onto nutrient agar plates. Sterile 6 mm paper discs were impregnated with 10 µL of JPWT prepared at 25 mg/mL or 50 mg/mL (diluted in 10% Tween 80) and placed on the inoculated plates. Gentamicin 10 µg/disc (CN) and imipenem 10 µg/disc (IPM) were used as positive controls. Plates were incubated at 37°C for 24 h, and inhibition zones were measured in millimeters. Each assay was performed in triplicate.

2.7. GCMS analysis

Weigh 10 mg of the JPWT extract and add 1 ml of MeOH. After vortexing and ultrasonic solubilization, the solution is filtered. 100 µl of the filtered solution is taken and dried with nitrogen, then 100 µl of BSTFA (N, O-bis(trimethylsilyl)trifluoroacetamide) is added, and the mixture is incubated at 70°C for 20 min. 2 µl is injected for GC-MS analysis. GC-MS analysis was performed using an Agilent 8890 gas chromatograph coupled to an Agilent 7000D mass spectrometer. Separation was achieved on an HP-5MS capillary column (30 m × 0.25 mm i.d., 0.25 µm film thickness). Helium was used as the carrier gas at a constant flow rate of 1.2 mL/min. The oven temperature was programmed from 60 °C to 300 °C. The mass spectrometer operated in electron impact (EI) mode at 70 eV, with a source temperature of 230 °C. Mass spectra were recorded in scan mode over the m/z range 30–500, with a solvent delay of 4 min.

2.8. Preparation of proteins and docking protocol in MOE

To evaluate protein-ligand interactions, the crystal structures 4HBT (CTX-M-15 β-lactamase) and 5M19 (PBP2a) were prepared in MOE (2024.06) by deleting non-essential molecules, adding missing hydrogens, and assigning appropriate protonation states. The six major constituents hydroxychavicol, 2,3-dehydroferruginol, eugenol, 3-methylcatechol, palmitic acid, and pyrocatechol were converted to MOE-compatible format and briefly minimized to remove any steric clashes [25]. Because 4HBT has no co-crystallized ligand, docking was performed in blind mode (no explicit “box” parameters in MOE), using Triangle Matcher for placement, London dG for initial scoring, and GBVI/WSA dG for refinement; each ligand underwent 15 independent runs, and the top 5 poses per ligand were retained. For 5M19, the protocol was validated by redocking the co-crystallized inhibitor at the exact experimental coordinates (MOE does not require box dimensions; the site is defined by the co-crystal position), yielding a heavy atom RMSD of 0.60 Å, which supports the reliability of the subsequent docking runs applied to the six constituents.

2.9. Statistical analysis

All experiments were performed at least in triplicate (n = 3). Results are expressed as mean ± standard deviation (SD). Statistical differences between groups were assessed using one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. Differences were considered statistically significant at p < 0.05.

3. Results

3.1. Preliminary phytochemical tests

Phytochemical screening was conducted to determine the presence (+) or absence (-) of principal secondary metabolites, namely, alkaloids, polyphenols, flavonoids, tannins, and saponins in JTWT. Qualitative determination of the JTWT extract determined the presence of multiple bioactive compounds, especially tannins, polyphenols, and flavonoids, but no saponins were present (Table 1).

Table 1. Screening of phytochemicals in Juniperus phoenicea wood tar.

Plant Extract Tanin Alkaloid Polyphenols Saponin Flavonoid
JPWT + + + – +

+ indicates the presence of secondary metabolites in extracts, while – indicates the absence in qualitative screening phytochemical analysis.

3.2. Total chemical quantification

The quantification of secondary metabolites revealed that JPWT contained substantial amounts of tannins (110.59 ± 11.31 µg TAE/mg), polyphenols (242.91 ± 68.93 µg GAE/mg) and flavonoids (26.74 ± 0.52 µg QE/mg) (Table 2).

Table 2. Total phenolic, flavonoids, and Tannins contents in Juniperus phoenicea wood tar.

Plant extract TTC (µg TAE/mg) TPC (µg GAE/mg) TFC (µg QE/mg)
JPWT 110.59 ± 11.31a 242.91 ± 68.93b 26.74 ± 0.52a

Data represents the mean ± standard deviation of three independent experiments. Values in the same row followed by different superscript letters (a-b) are significantly different according to Tukey’s test (p < 0.05). A Tukey’s test (α = 0.05) revealed no significant difference between TFC and TTC (p = 0.186). In contrast, TFC showed a significant difference compared to TTC (p = 0.047). A highly significant difference was observed between TPC and TFC (p = 0.004). These results indicate that TPC differs significantly from both TTC and TFC, whereas TFC and TTC present comparable mean values.

3.3. GCMS analysis

GC-MS analysis of JPWT led to the identification of 17 compounds (Table 4). The profile was dominated by phenolic and diterpenoid constituents, with hydroxychavicol (46.3%) and 2,3-dehydroferruginol (18.5%) as the most abundant compounds, followed by eugenol (7.3%) and isoeugenol (3.9%). The predominance of these compounds may contribute to the observed antioxidant and antibacterial activities Table 3 and Fig 1.

Table 4. Antioxidant activity of JPWT (IC50 µg/mL; mean ± SD, n = 3).

Assays JPWT Positive control
BHT Ascorbic acid
DPPH 17.05 ± 0.67a 24.02 ± 2.03a 1.996 ± 0.1a
FRAP 75.81 ± 2.02a 16.7 ± 1.6b ---

IC50 = Half maximal inhibitory concentration. Different superscript letters within the same row indicate significant differences according to Tukey’s test (α = 0.05). The results are expressed as mean values and standard deviation (n = 3). Tukey’s test (α = 0.05) for the DPPH radical scavenging assay showed no significant difference between BHT and JPWT (p = 0.341) nor between Ascorbic acid and JPWT (p = 0.070). In contrast, an important difference was observed between Ascorbic acid and BHT (p = 0.025). While no significant differences were observed between JPWT and the reference antioxidants in the DPPH assay (p > 0.05), a different trend was noted in the FRAP assay. Tukey’s test revealed a significant difference between JPWT and BHT in FRAP (p = 0.001). Overall, these results indicate that JPWT exhibits DPPH radical scavenging activity comparable to both reference antioxidants, while showing a superior reducing capacity compared to the synthetic antioxidant (BHT), and a clear difference was observed between BHT and ascorbic acid.

Table 3. Chemical composition of JPWT as identified by GC-MS.

N° Name of compounds Retention time (min) Area (%)
1 Phenol 14.58 0.65
2 3-Methylphenol 17.04 0.28
3 4-Methylphenol 17.41 0.83
4 2-Methylphenol 17.73 1.05
5 Pyrocatechol 24.12 14.21
6 3-Methylcatechol 25.78 15.13
7 2,3-Dimethylhydroquinone 27.04 7.74
8 3-Isopropylpyrocatechol 28.24 2.81
9 Eugenol 28.61 11.37
10 Hydroxychavicol 29.63 1.92
11 3-Vanilpropanol 31.64 3.73
12 Palmitic Acid 33.82 5.36
13 2,3-Dehydroferruginol 35.75 6.45
14 Pisiferal 36.55 13.21
15 Homovanillyl alcohol 37.24 3.65
16 Ethisterone, trimethylsilyl ether, O-methyloxime 38.83 7.10
17 4,4’-Methylenebis [2-nitrobenzenamine] 41.16 4.44

Fig 1. GC-MS of JPWT showing the identified phytochemical constituents.

Fig 1

3.4. Antioxidant activities

According to Table 3 findings, JPWT demonstrates significant antioxidant properties compared to the standard antioxidants BHT and Ascorbic acid, used as reference points (p < 0.05). The extract shows strong scavenging action on DPPH radicals and FRAP assays, with IC50 values of 17.05 ± 0.67 and 75.81 ± 2.02 μg/mL, respectively. Nevertheless, this reducing power is still less active as of the synthetic antioxidants BHT (IC50 = 24.02 ± 2.03 μg/mL) and Ascorbic acid (IC50 = 1.996 ± 0.1 μg/mL). Furthermore, in the FRAP assay, BHT reduces iron with an IC50 of 16.7 ± 1.6 μg/mL (p < 0.05) Table 3.

3.5. Antibacterial activity

JPWT exhibited antibacterial activity against the tested strains (Table 5). Inhibition zones increased with concentration, indicating dose-dependent effects. Overall, Gram-positive bacteria (Staphylococcus aureus and Enterococcus faecalis) were more susceptible than Gram-negative strains, which is consistent with the barrier effect of the outer membrane in Gram-negative bacteria. Among the Gram-positive bacteria, Staphylococcus aureus (methicillin-resistant, MRSA) and Staphylococcus aureus ATCC were the most susceptible to JPWT, with inhibition zones of 12.5 ± 0.70 mm and 13 ± 0.0 mm, respectively, at 50 mg/mL, compared to 8 ± 1.41 mm and 10 ± 0.0 mm at 25 mg/mL. Enterococcus faecalis exhibited moderate sensitivity, with inhibition zones measuring 6.5 ± 0.70 mm at 25 mg/mL and 11 ± 1.41 mm at 50 mg/mL. Compared to the reference antibiotic gentamicin (CN), which produced inhibition zones ranging from 10 ± 0.0 to 21 ± 0.70 mm, the extract showed lower but still notable activity, particularly against Staphylococcus species. For Gram-negative bacteria, JPWT had generally weaker inhibitory effects. Pseudomonas aeruginosa ATCC showed minimal sensitivity, maintaining an inhibition zone of 8 ± 0.0 mm at both concentrations, whereas imipenem (IPM), used as a positive control, produced a zone of 23 ± 0.0 mm. Conversely, Escherichia coli (ESBL-producing) showed moderate susceptibility to JPWT, with inhibition zones increasing from 6 ± 0.0 mm at 25 mg/mL to 12.5 ± 0.70 mm at 50 mg/mL, indicating a dose-dependent effect. The extract also had limited activity against carbapenem-resistant E. coli and E. coli ATCC, with inhibition zones ranging from 6 ± 0.0 to 9 ± 0.0 mm, while positive controls imipenem and gentamicin produced inhibition zones varying from 0 ± 0.0 to 25 ± 0.0 mm depending on the strain Table 5.

Table 5. Inhibition zone diameter (mm) (mean ± SD, n = 3) of JPWT against selected bacteria and positive controls.

Bacterial strain Inhibition zone (mm) Positive control (Antibiotic)
25 mg/mL 50 mg/mL
Staphylococcus aureus (methicillin-resistant, MRSA) 8 ± 1.41a 12.5 ± 0.70b (CN) – 21 ± 0.70c
Staphylococcus aureus ATCC 10 ± 0a 13 ± 0b (CN) – 19 ± 0c
Enterococcus faecalis 6.5 ± 0.70a 11 ± 1.41a (CN) – 10 ± 0a
Pseudomonas aeruginosa ATCC 8 ± 0a 8 ± 0a (IPM) – 23 ± 0b
Escherichia coli (ESBL-producing) 6 ± 0a 12.5 ± 0.70b (IPM) – 22 ± 1.41c
Escherichia coli (carbapenem-resistant) 7 ± 0a 7 ± 0a (CN) – 0 ± 0a
Escherichia coli ATCC 6 ± 0a 9 ± 0b (IPM) – 25 ± 0c

Data represent the mean ± standard deviation of three independent experiments. Different superscript letters within the same row indicate significant differences according to Tukey’s post hoc test (α = 0.05). Tukey’s post hoc test (α = 0.05) revealed a significant difference between the concentrations of 50 mg/mL and 25 mg/mL for most tested strains, except for Pseudomonas aeruginosa. Comparisons with reference antibiotics showed significant differences between both concentrations and Gentamicin for MRSA and Staphylococcus aureus ATCC, while no significant differences were observed for Enterococcus faecalis. For Gram-negative bacteria, Imipenem differed significantly from 25 mg/mL for P. aeruginosa and ESBL-producing strains, whereas a significant difference with 50 mg/mL was observed only for ESBL strains.

3.6. Molecular docking

Table 6 shows that two hydrophobic scaffolds dominate across both targets. For PBP2a (5M19), 2,3-dehydroferruginol (−7.04 kcal·mol ⁻ ¹) and palmitic acid (−6.45 kcal·mol ⁻ ¹) yield the most favorable scores, each surpassing the re-docked co-crystal reference (−5.50 kcal·mol ⁻ ¹; 0.60 Å RMSD), which indicates pose fidelity and suggests these phytochemicals can compete effectively at the PBP2a binding site. The smaller phenolics eugenol, hydroxychavicol, 3-methylcatechol, and pyrocatechol (≈ −4.2 to −4.8 kcal·mol ⁻ ¹) score consistently weaker, consistent with limited hydrophobic surface complementarity needed to stabilize interactions in PBP2a. For CTX-M-15 (4HBT) docked in blind mode due to the apo structure palmitic acid again ranks first (−6.01 kcal·mol ⁻ ¹) followed by 2,3-dehydroferruginol (−5.34 kcal·mol ⁻ ¹), while the remaining phenolics cluster around −4.0 to −4.6 kcal·mol ⁻ ¹, indicating modest affinity. The cross-target convergence therefore nominates palmitic acid and 2,3-dehydroferruginol as priority leads for follow-up against both MRSA PBP2a and ESBL CTX-M-15 (Figs 2, 3).

Table 6. MOE docking energies (kcal·mol ⁻ ¹) of six major constituents against PBP2a (5M19) and CTX-M-15 β-lactamase (4HBT), with co-crystal redocking control for 5M19.

Binding Energy (Kcal/mol)
PDB code/compounds 5M19 4HBT
Hydroxychavicol −4.71 −4.46
2,3-Dehydroferruginol −7.04 −5.34
Eugenol −4.79 −4.58
3-Methylcatechol −4.17 −4.13
Palmitic Acid −6.45 −6.01
Pyrocatechol −4.19 −3.96
Co-5M19 −5.50 ***
4HBT *** ***

Fig 2. 2D/3D binding poses and interaction fingerprints of palmitic acid and 2,3-dehydroferruginol in PBP2a (PDB 5M19), showing convergence to the same lipophilic cleft.

Fig 2

Fig 3. 2D/3D binding poses and interaction fingerprints of palmitic acid and 2,3-dehydroferruginol in CTX-M-15β-lactamase (PDB 4HBT), showing occupation of distinct micro-sites.

Fig 3

4. Discussion

JPWT showed a broad qualitative phytochemical profile, with detectable polyphenols, tannins, flavonoids and alkaloids (Table 1) [26]. The high levels of total polyphenols and tannins (Table 2) are consistent with the radical-scavenging and reducing capacities observed in DPPH and FRAP assays (Table 3). Antioxidants protect biological systems against oxidative stress by scavenging free radicals and preventing lipid peroxidation. Currently, plant-derived natural antioxidants are increasingly recommended for the prevention and treatment of various diseases [27]. The antioxidant activity of JPWT was evaluated using the DPPH assay, a widely accepted method for assessing free radical scavenging capacity [28]. JPWT exhibited strong antioxidant activity with an IC₅₀ value of 17.05 ± 0.67 µg/mL, which was higher than BHT (IC₅₀ = 24.02 ± 2.03 µg/mL) but lower than ascorbic acid (IC₅₀ = 1.996 ± 0.1 µg/mL), in agreement with previous studies [26]. The FRAP assay, a rapid and cost-effective method for evaluating total antioxidant capacity [29], showed that BHT had the highest ferric reducing power, whereas JPWT displayed a lower reducing capacity (75.81 ± 2.02 µg/mL). This activity is likely related to the presence of secondary metabolites (Table 4), particularly phenolic constituents such as hydroxychavicol and eugenol, which are known to act as hydrogen/electron donors and can therefore contribute to antioxidant activity [30–32]. However, Tannins, and flavonoids compounds can contribute to reducing oxidative stress and lowering the risk of metabolic and degenerative disorders [33–38].

The GC–MS analysis of JPWT (Table 3) revealed a complex phytochemical composition mainly characterized by phenolic derivatives and diterpenoid compounds. The most abundant constituents were 3-methylcatechol (15.13%), pyrocatechol (14.21%). Several bioactive constituents were identified, including phenol and its methylated derivatives (2-, 3-, and 4-methylphenol), catechol derivatives (pyrocatechol, 3-methylcatechol, 2,3-dimethylhydroquinone, and 3-isopropylpyrocatechol), as well as eugenol, homovanillyl alcohol, hydroxychavicol, palmitic acid, 3-vanilpropanol, 2,3-dehydroferruginol, pisiferal, ethisterone trimethylsilyl ether O-methyloxime, and 4,4’-methylenebis [2-nitrobenzenamine] [39]. These compounds are widely reported to exhibit antimicrobial, antioxidant, anti-inflammatory, and anticancer activities, while palmitic acid has been associated with lipid metabolism and cardiovascular effects [31,40–49]. Similar phenolic and terpenoid constituents have been reported in Juniperus phoenicea derived preparations and are frequently linked to antimicrobial and antioxidant activities [50,51]. Although essential oils and wood tars differ in extraction processes and chemical composition, the presence of these bioactive compounds supports the pharmacological potential of JPWT and corroborates the biological activities observed in the present study.

Over the past three decades, pharmaceutical companies have created a variety of innovative antibiotic treatments, but bacteria have grown more resistant to these medications. Plant extracts are a fantastic source of pathogen-fighting antibacterial compounds [52]. They can therefore be utilized to treat a variety of infectious disorders brought on by virulent microorganisms. In the antibacterial screening, JPWT was more active against Gram-positive strains than Gram-negative bacteria (Table 5). This trend is commonly attributed to the presence of an outer membrane in Gram-negative bacteria, which restricts the penetration of hydrophobic compounds. Phenolic compounds can disrupt bacterial membranes and interfere with enzyme systems, which may explain the inhibitory effects observed for JPWT. Additionally, there are not many reports on the antibacterial properties of JPWT. The results of the current investigation make it abundantly evident that JPWT proven to have significant antibacterial activity.

Structure-based molecular docking offers a mechanistic bridge between our disc-diffusion phenotypes and atomistic recognition at resistance-defining enzymes, enabling us to rationalize activity and prioritize leads before costly assays. Guided by the highest inhibition zones observed against ESBL E. coli and MRSA, we focused on two clinically pivotal targets: CTX-M-15, a class A extended-spectrum β-lactamase (PDB 4HBT) that hydrolyzes third-generation cephalosporins and undermines β-lactam efficacy in Gram-negative pathogens, and PBP2a, the low-affinity penicillin-binding protein (PDB 5M19) that preserves transpeptidation and cell-wall cross-linking in MRSA despite β-lactam exposure [53]. Docking these enzymes against our six major constituents hydroxychavicol, 2,3-dehydroferruginol, eugenol, 3-methylcatechol, palmitic acid, and pyrocatechol probes complementary interaction chemistries: phenolic donors/acceptors to engage catalytic serine-centered machinery and polar subsites, and hydrophobic/aryl surfaces to occupy lipophilic grooves and π-stacking regions that modulate catalysis or access channels. By estimating relative binding affinities and preferred poses, docking tests the plausibility that these phytochemicals can attenuate β-lactamase turnover or disrupt PBP-mediated cross-linking, thereby offering a structure-guided rationale for the observed antibacterial trends across Gram-negative and Gram-positive backgrounds.

Fig 2 (2D/3D) depicts the interaction fingerprints, and the 3D pose overlays of 2,3-dehydroferruginol and palmitic acid in PBP2a (5M19), showing that both ligands occupy essentially the same subsite within a continuous lipophilic cleft bounded on the polar edge by Lys148-Glu239-Arg241 and along the hydrophobic wall by Val256/Val277-Pro258-Met372. In 2D, 2,3-dehydroferruginol presents its phenolic/aromatic head toward Arg241, consistent with a side-chain H-bond/cation-π anchor, while its fused hydrocarbon core packs against Val277/Pro258 with additional van der Waals contacts to Gly257/Met372 [54,55]; the 3D view corroborates deep insertion and tight contour complementarity throughout this groove. Palmitic acid follows the same trajectory: the long aliphatic chain traces the Val-Pro-Met hydrophobic track, whereas the carboxyl headgroup orients toward Lys148 (side-chain donor H-bond) with a secondary polar engagement to Arg241; in 3D, the head sits at the polar rim while the tail fully buries along the cleft, consistent with the 2D exposure halos. The pose convergence of these chemically distinct ligands in the same pocket explains their similarly favorable docking energies in Table 1, with 2,3-dehydroferruginol slightly outperforming palmitic acid due to additional π-driven stabilization around Arg241 and superior shape complementarity evident in both the 2D contacts and the 3D overlays.

Based on the 2D/3D visualization in Fig 3, both ligands bind within the CTX-M-15 β-lactamase (4HBT) pocket but occupy distinct micro-sites that explain their energy ranking in Table 6. 2,3-Dehydroferruginol settles on a predominantly hydrophobic shelf flanked by Val30/Val284/Leu288/Ile283-Ile58 and bordered peripherally by Asp29/Asp286/Asp54, with only weak polar opportunities nearby [55–57]; its aromatic-alicyclic framework is stabilized mainly by dispersion/van der Waals contacts and shows noticeable ligand exposure in the 2D map, consistent with a shallower, entrance-proximal pose and a moderate score (−5.34 kcal·mol ⁻ ¹). In contrast, palmitic acid threads along an elongated tunnel that traverses the catalytic rim engaging the Ser130 region and the β3-β4 segment (Lys234-Thr235-Ser237-Gly238/Gly239) while running parallel to the Ω-loop residues (Thr168/Thr171/Asn170). The carboxyl headgroup forms a small H-bond network (Ser237/Thr235, with possible electrostatic assistance from Lys234), whereas the aliphatic chain is deeply buried against the lipophilic track, producing minimal exposure across the chain in 2D and a snug, continuous burial in 3D. This combination of specific polar anchoring near the catalytic machinery and extensive hydrophobic complementarity rationalizes the more favorable docking energy for palmitic acid (−6.01 kcal·mol ⁻ ¹) relative to 2,3-dehydroferruginol, and supports the hypothesis that palmitate-like scaffolds can more effectively occupy the active-site corridor of CTX-M-15 and potentially impede access/turnover of β-lactam substrates [58,59].

Overall, the docking analysis (Table 6; Figs 2, 3) identifies palmitic acid and 2,3-dehydroferruginol as the most promising binders across both targets. On PBP2a, the two ligands converge into the same lipophilic pocket with extensive nonpolar burial, whereas on CTX-M-15 palmitic acid penetrates deeper into the active-site corridor with more balanced polar/hydrophobic complementarity explaining its superior score. The workflow is supported by sub-ångström redocking accuracy on PBP2a (RMSD = 0.60 Å), whereas the apo CTX-M-15 poses require further structural refinement and conformational optimization before proceeding to biochemical validation.

Our findings suggest that JPWT may serve as a natural antioxidant capable of mitigating oxidative stress. However, further studies are required to isolate and purify the bioactive compounds responsible for their antioxidant and antibacterial activities. From an applied perspective, wood tars obtained from conifers are traditionally produced and used in Morocco [60,61], but their production can raise sustainability concerns if harvesting is not controlled. Ethnobotanical investigations have highlighted the socio-economic importance of medicinal tars as well as the potential pressure on local biodiversity [60,62]. The valorization of JPWT as a source of natural antimicrobial and antioxidant agents should therefore be coupled with sustainable collection practices. In addition, because GC-MS mainly detects volatile/semi-volatile constituents (often after derivatization), complementary techniques such as LC-MS/MS are recommended in future work to better characterize non-volatile polar metabolites.

5. Conclusions

This study establishes that JPWT exhibits significant antioxidant and antimicrobial activities, largely attributable to its abundant phenolic, tannin, and flavonoid constituents. GC-MS profiling uncovered a diverse chemical composition predominantly featuring hydroxychavicol, eugenol, and 2,3-dehydroferruginol compounds recognized for their established biological properties. Molecular docking studies corroborated antimicrobial experimental findings, revealing strong binding interactions between palmitic acid and 2,3-dehydroferruginol with critical bacterial targets (PBP2a and CTX-M-15 β-lactamase), thereby offering mechanistic insights into the observed antimicrobial effects. These results position JPWT as a promising natural product for further development. However, additional studies are required to isolate active compounds, determine MIC/MBC values, assess safety, and evaluate efficacy in relevant in vivo models. Sustainable valorization of traditional wood tar resources could also contribute to local socio-economic development when coupled with conservation-oriented practices

Acknowledgments

This work was supported and funded by the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSIU-DDRSP2601). The authors gratefully acknowledge the HPC Marwan team for providing access to high-performance computing resources used to perform the molecular docking calculations. We also thank all colleagues who contributed to sample collection and laboratory assistance.

Data Availability

Data are available from the: https://github.com/khibech/Juniperus-phoenicea-.

Funding Statement

This work was supported and funded by the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSIU-DDRSP2601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Nieto Feliner G, Cellinese N, Crowl AA, Frajman B. Editorial: Understanding plant diversity and evolution in the Mediterranean Basin. Front Plant Sci. 2023;14:1152340. doi: 10.3389/fpls.2023.1152340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Marañón T, Ajbilou R, Ojeda F, Arroyo J. Biodiversity of woody species in oak woodlands of southern Spain and northern Morocco. For Ecol Manage. 1999;115:147–56. doi: 10.1016/S0378-1127(98)00395-8 [DOI] [Google Scholar]
  • 3.Zouhri A, El-Mernissi Y, El Menyiy N, Bouddine T, Mir N, El Aissaoui K. A review of Moroccan medicinal plants used in the treatment of inflammation. Not Sci Biol. 2023;15:11414–11414. doi: 10.55779/NSB15111414 [DOI] [Google Scholar]
  • 4.Ait-Sidi-Brahim M, Markouk M, Larhsini M. Moroccan medicinal plants as antiinfective and antioxidant agents. New look to phytomedicine: Advancements in herbal products as novel drug leads. 2019. p. 91–142. doi: 10.1016/B978-0-12-814619-4.00005-7 [DOI] [Google Scholar]
  • 5.El Ouardi M, Drioiche A, El Makhoukhi F, Mabrouki J, Hakmi M, Al Kamaly O, et al. Chemical composition, antimicrobial, and antioxidant properties of essential oils from Artemisia herba-alba asso. and Artemisia huguetii caball. from Morocco: in vitro and in silico evaluation. Front Chem. 2024;12:1456684. doi: 10.3389/fchem.2024.1456684 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bibow A, Oleszek W. Essential Oils as Potential Natural Antioxidants, Antimicrobial, and Antifungal Agents in Active Food Packaging. Antibiotics (Basel). 2024;13(12):1168. doi: 10.3390/antibiotics13121168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Brochot A, Guilbot A, Haddioui L, Roques C. Antibacterial, antifungal, and antiviral effects of three essential oil blends. Microbiologyopen. 2017;6(4):e00459. doi: 10.1002/mbo3.459 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Patel PR, Patel VR, Kajal SS. Antioxidant activity of some selected medicinal plants in Western Region of India. Adv Biol Res. 2010;4:23–6. [Google Scholar]
  • 9.Ghosh R, Alajbegovic A, Gomes AV. NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species. Oxid Med Cell Longev. 2015;2015:536962. doi: 10.1155/2015/536962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Živić N, Milošević S, Dekić V, Dekić B, Ristić N, Ristić M, et al. Phytochemical and antioxidant screening of some extracts of Juniperus communis L. and Juniperus oxycedrus L. Czech J Food Sci. 2019;37(5):351–8. doi: 10.17221/28/2019-cjfs [DOI] [Google Scholar]
  • 11.Godron M, Forman RTT. Landscape modification and changing ecological characteristics. Disturbance and ecosystems. 1983. p. 12–28. doi: 10.1007/978-3-642-69137-9_2 [DOI] [Google Scholar]
  • 12.Gauquelin T, Bertaudière V, Cambecèdes J, Largier G. Le genevrier thurifère (Juniperus thurifera L.) dans les Pyrénées: état de conservation et perspectives. N/A. N/A(N/A):N/A. [Google Scholar]
  • 13.Ramdani MR, Harmand JC, Glas F, Patriarche G, Travers L. Arsenic Pathways in Self-Catalyzed Growth of GaAs Nanowires. Crystal Growth & Design. 2012;13(1):91–6. doi: 10.1021/cg301167g [DOI] [Google Scholar]
  • 14.Barnes TM, Greive KA. Topical pine tar: History, properties and use as a treatment for common skin conditions. Australas J Dermatol. 2017;58(2):80–5. doi: 10.1111/ajd.12427 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Harborne JB. Chlorophyll extraction. Phytochem. 1973;:205–7. [Google Scholar]
  • 16.Audu S, Mohammed I. Phytochemical screening of the leaves of Lophira lanceolata (Ochanaceae). HK-LS. 2007;4:1097. [Google Scholar]
  • 17.Kalemba D, Kunicka A. Antibacterial and antifungal properties of essential oils. Curr Med Chem. 2003;10(10):813–29. doi: 10.2174/0929867033457719 [DOI] [PubMed] [Google Scholar]
  • 18.Obasi NL, Egbuonu ACC, Ukoha PO, Ejikeme PM. Comparative phytochemical and antimicrobial screening of some solvent extracts of Samanea saman. African Journal of Pure and Applied Chemistry. 2010;4:206–2012. [Google Scholar]
  • 19.Ndayambaje M, Habyarimana T, Wahnou H, Nsanzurwimo A, Chgari O, Ndishimye P, et al. Antioxidant capacity, acute and sub-acute oral toxicity, and in vivo anti-inflammatory effects of Tetradenia riparia hydroalcoholic extract. Drug Chem Toxicol. 2025;48(6):1293–306. doi: 10.1080/01480545.2025.2468932 [DOI] [PubMed] [Google Scholar]
  • 20.Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic. 1965;16:144–58. [Google Scholar]
  • 21.Topçu G, Ay M, Bilici A, Sarıkürkcü C, Öztürk M, Ulubelen A. A new flavone from antioxidant extracts of Pistacia terebinthus. Food Chemistry. 2007;103(3):816–22. doi: 10.1016/j.foodchem.2006.09.028 [DOI] [Google Scholar]
  • 22.Folin O, Ciocalteu V. On tyrosine and tryptophane determinations in proteins. J Biol Chem. 1927;73:627–50. [Google Scholar]
  • 23.Şahin F, Güllüce M, Daferera D, Sökmen A, Sökmen M, Polissiou M, et al. Biological activities of the essential oils and methanol extract of Origanum vulgare ssp. vulgare in the Eastern Anatolia region of Turkey. Food Control. 2004;15(7):549–57. doi: 10.1016/j.foodcont.2003.08.009 [DOI] [Google Scholar]
  • 24.Yen G-C, Chen H-Y. Antioxidant Activity of Various Tea Extracts in Relation to Their Antimutagenicity. J Agric Food Chem. 1995;43(1):27–32. doi: 10.1021/jf00049a007 [DOI] [Google Scholar]
  • 25.Elkanzi NAA, Kadry AM, Ryad RM, Bakr RB, Ali El-Remaily MAEAA, Ali AM. Efficient and recoverable bio-organic catalyst cysteine for synthesis, docking study, and antifungal activity of new bio-active 3,4-dihydropyrimidin-2(1H)-ones/thiones under microwave irradiation. ACS Omega. 2022;7:22839–49. doi: 10.1021/ACSOMEGA.2C02449 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.El Jemli M. Contribution to the ethnobotanical, toxicological, pharmacological and phytochemical study of four Moroccan Cupressaceae: Juniperus thurifera L., Juniperus oxycedrus L., Juniperus phoenicea L. and Tetraclinis articulata L. 2020.
  • 27.Paudel MR, Chand MB, Pant B, Pant B. Assessment of Antioxidant and Cytotoxic Activities of Extracts of Dendrobium crepidatum. Biomolecules. 2019;9(9):478. doi: 10.3390/biom9090478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Raghavendra H. Antiradical and lipid peroxidation inhibitory activity of ripe and unripe fruit of Rubus steudneri Schweinf. (Rosaceae). Pharmacognosy Journal. 2018. doi: 10.5530/pj.2018.4.139 [DOI] [Google Scholar]
  • 29.Gülçin İ. Antioxidant activity of food constituents: an overview. Arch Toxicol. 2012;86(3):345–91. doi: 10.1007/s00204-011-0774-2 [DOI] [PubMed] [Google Scholar]
  • 30.Sharma S, Khan IA, Ali I, Ali F, Kumar M, Kumar A, et al. Evaluation of the antimicrobial, antioxidant, and anti-inflammatory activities of hydroxychavicol for its potential use as an oral care agent. Antimicrob Agents Chemother. 2009;53(1):216–22. doi: 10.1128/AAC.00045-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zari AT, Zari TA, Hakeem KR. Anticancer Properties of Eugenol: A Review. Molecules. 2021;26:7407. doi: 10.3390/MOLECULES26237407 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Tina S, Khibech O, Zourif A, Iskandar S, Mohamed KH, Ndayambaje M, et al. Phytochemical characteristics, antioxidant, and antimicrobial activities and in silico prediction of bioactive compounds from Cedrus atlantica wood tar. Biophysica. 2025;6:3. doi: 10.3390/BIOPHYSICA6010003 [DOI] [Google Scholar]
  • 33.Bertelli A, Biagi M, Corsini M, Baini G, Cappellucci G, Miraldi E. Polyphenols: From Theory to Practice. Foods. 2021;10:2595. doi: 10.3390/FOODS10112595 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kouvari M, D’Cunha NM, Travica N, Sergi D, Zec M, Marx W, et al. Metabolic Syndrome, Cognitive Impairment and the Role of Diet: A Narrative Review. Nutrients. 2022;14(2):333. doi: 10.3390/nu14020333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Silveira AC, Dias JP, Santos VM, Oliveira PF, Alves MG, Rato L, et al. The Action of Polyphenols in Diabetes Mellitus and Alzheimer’s Disease: A Common Agent for Overlapping Pathologies. Curr Neuropharmacol. 2019;17(7):590–613. doi: 10.2174/1570159X16666180803162059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Heinrich M, Mah J, Amirkia V. Alkaloids used as medicines: Structural phytochemistry meets biodiversity—An update and forward look. Molecules. 2021;26. doi: 10.3390/MOLECULES26071836 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Salas-Salvadó J, Guasch-Ferré M, Merino J, Sun Q, Fitó M. Dietary polyphenols, Mediterranean diet, prediabetes, and type 2 diabetes: A narrative review of the evidence. Oxid Med Cell Longev. 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kurek J. Alkaloids: their importance in nature and human life. BoD–Books on Demand. 2019. [Google Scholar]
  • 39.Khare CP. Indian medicinal plants: an illustrated dictionary. Springer Science & Business Media. 2008. [Google Scholar]
  • 40.Davidson PM, Branden AL. Antimicrobial Activity of Non-Halogenated Phenolic Compounds. J Food Prot. 1981;44(8):623–32. doi: 10.4315/0362-028X-44.8.623 [DOI] [PubMed] [Google Scholar]
  • 41.Kim BC, Kim H, Lee HS, Kim SH, Cho D-H, Jung HJ, et al. 4-Chloro-2-Isopropyl-5-Methylphenol Exhibits Antimicrobial and Adjuvant Activity against Methicillin-Resistant Staphylococcus aureus. J Microbiol Biotechnol. 2022;32(6):730–9. doi: 10.4014/jmb.2203.03054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Abed Saoud S, Fahad Ali K, Mustafa Shakir R. Relationship Between the structure of Newly Synthesized derivatives of 1,3,4-oxadiazole Containing 2-Methylphenol and their Antioxidant and Antibacterial Activities. Orient J Chem. 2017;33(04):1781–98. doi: 10.13005/ojc/330423 [DOI] [Google Scholar]
  • 43.Sahni T, Sharma S, Verma D, Sharma P, Kaur S. Antioxidant and antibacterial evaluation of 2,6-dimethoxy-4-((phenylamino) methyl) phenol and 2,6-dimethoxy-4-((4′-nitrophenylimino)methyl) phenol. Biological Forum-An International Journal. 2022;14:1. [Google Scholar]
  • 44.Riahi L, Elferchichi M, Ghazghazi H, Jebali J, Ziadi S, Aouadhi C, et al. Phytochemistry, antioxidant and antimicrobial activities of the essential oils of Mentha rotundifolia L. in Tunisia. Industrial Crops and Products. 2013;49:883–9. doi: 10.1016/j.indcrop.2013.06.032 [DOI] [Google Scholar]
  • 45.Funakoshi-Tago M, Nonaka Y, Tago K, Takeda M, Ishihara Y, Sakai A, et al. Pyrocatechol, a component of coffee, suppresses LPS-induced inflammatory responses by inhibiting NF-κB and activating Nrf2. Sci Rep. 2020;10(1):2584. doi: 10.1038/s41598-020-59380-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Mohamad NA, Rahman AA, Sheikh Abdul Kadir SH. Hydroxychavicol as a potential anticancer agent (Review). Oncol Lett. 2022;25(1):34. doi: 10.3892/ol.2022.13620 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Murru E, Manca C, Carta G, Banni S. Impact of dietary palmitic acid on lipid metabolism. Front Nutr. 2022;9:861664. doi: 10.3389/FNUT.2022.861664 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Jiang H, Na C, Zhu Y, Bi Y, Yang R, Yang R, et al. Multiple Roles of Palmitic Acid in Cardiovascular Diseases. J Inflamm Res. 2025;18:14515–33. doi: 10.2147/JIR.S530054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Sabbineni J. Phenol-an effective antibacterial agent. JOMC. 2016;3:185. [Google Scholar]
  • 50.Asbabou A, Hanane T, Gourich AA, Siddique F, Drioiche A, Remok F, et al. Phytochemical profile, physicochemical, antioxidant and antimicrobial properties of Juniperus phoenicea and Tetraclinis articulate: in vitro and in silico approaches. Front Chem. 2024;12:1397961. doi: 10.3389/fchem.2024.1397961 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Chelouati T, Lafraxo S, Bouslamti M, El Barnossi A, Chebaibi M, Akhazzane M, et al. Study on antioxidant and antimicrobial potential of chemically profiled essential oils extracted from Juniperus phoenicea (L.) by use of in vitro and in silico approaches. Open Chemistry. 2023;21(1). doi: 10.1515/chem-2022-0333 [DOI] [Google Scholar]
  • 52.Hongal AM, Shettar AK, Hoskeri JH, Vedamurthy AB. GCMS-based phytochemical profiling and in vitro pharmacological activities of plant Alangium salviifolium (L.f) Wang. Future Journal of Pharmaceutical Sciences 2024 10:1. 2024;10: 1–19. doi: 10.1186/S43094-024-00631-3 [DOI] [Google Scholar]
  • 53.Shurina BA, Page RC. Structural Comparisons of Cefotaximase (CTX-M-ase) Sub Family 1. Front Microbiol. 2021;12:688509. doi: 10.3389/fmicb.2021.688509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Abbaoui Z, Khibech O, Oulous A, Karci H, Dündar M. In silico and in vitro evaluation of N -heterocyclic derivatives as antimicrobials: ADMET analysis, SAR, and molecular docking. 2025;1–19. [DOI] [PMC free article] [PubMed]
  • 55.Merimi C, Benabbou A, Fraj E, Khibech O, Yahyaoui MI, Asehraou A, et al. Valorization of Imidazolium-Based Salts as Next-Generation Antimicrobials: Integrated Biological Evaluation, ADMET, Molecular Docking, and Dynamics Studies. ASEAN J Sci Eng. 2025;6(1):11–34. doi: 10.17509/ajse.v6i1.89789 [DOI] [Google Scholar]
  • 56.Ouakil A, Lachkar N, Moussaid F, Khibech O, Lachkar M. Phytochemical profile, antioxidant and antimicrobial activities of aerial parts of Stachys germanica subsp. cordigera Briq: in vitro evaluation and in-silico molecular docking study. 2025;13:1548–65.
  • 57.Camargo PG, da Silva RB, Zuma AA, Garden SJ, Albuquerque MG, Rodrigues CR. In silico evaluation of N-aryl-1,10-phenanthroline-2-amines as potential inhibitors of T. cruzi GP63 zinc-metalloprotease by docking and molecular dynamics simulations. Sci Rep. 2025;15:6036. doi: 10.1038/s41598-025-90088-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004;3(11):935–49. doi: 10.1038/nrd1549 [DOI] [PubMed] [Google Scholar]
  • 59.Ramírez D, Caballero J. Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data?. Molecules. 2018;23:1–17. doi: 10.3390/molecules23051038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Julin M. Tar production-traditional medicine and potential threat to biodiversity in the Marrakesh region: An ethnobotanical study. 2008.
  • 61.Burri S, Alifriqui M, Bun SS, Cigerci IH, Robles - AAD, Marmouzi I. Des ressources naturelles à la santé. Les Nouvelles de l’archéologie. 2018;:62–9. doi: 10.4000/nda.4267 [DOI] [Google Scholar]
  • 62.Kargıoğlu M, Cenkci S, Serteser A, Konuk M, Vural G. Traditional uses of wild plants in the middle Aegean region of Turkey. Human Ecology. 2010;38:429–50. doi: 10.1007/s10745-010-9318-2 [DOI] [Google Scholar]

Decision Letter 0

Marcello Iriti

4 Jan 2026

Dear Dr. Tina,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 18 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols....

We look forward to receiving your revised manuscript.

Kind regards,

Marcello Iriti, Ph.D.

Academic Editor

PLOS One

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:-->--> -->-->GCMS-based phytochemical profiling and in vitro pharmacological activities of plant Alangium salviifolium (L.f) Wang - https://doi.org/10.1186/s43094-024-00631-3-->--> -->-->Phytochemical composition and in vitro antioxidant and antimicrobial activities of Bersama abyssinica F. seed extracts - https://doi.org/10.1038/s41598-024-56659-1-->--> -->-->In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.-->--> -->-->3. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why.-->--> -->-->4. Thank you for stating the following financial disclosure: -->-->Biology Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSIU-DDRSP2501), Riyadh, 11623, Saudi Arabia  -->--> -->-->Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." -->-->If this statement is not correct you must amend it as needed. -->-->Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.-->--> -->-->5. Thank you for stating the following in the Acknowledgments Section of your manuscript: -->-->This work was supported and funded by the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IM-SIU-DDRSP2501). We gratefully acknowledge the HPC Marwan team for granting us privileged access to their high-performance computing resources. The exceptional computational power and responsive technical support they provided were instrumental in carrying out the molecular-dynamics simulations reported in this study. Their contribution greatly enhanced the quality and robustness of our results, and we are sincerely thankful for their assistance.-->--> -->-->We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. -->-->Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: -->-->Biology Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSIU-DDRSP2501), Riyadh, 11623, Saudi Arabia -->--> -->-->Please include your amended statements within your cover letter; we will change the online submission form on your behalf.-->--> -->-->6. Please upload a new copy of Figures 1 and 2 as the detail is not clear. Please follow the link for more information:  https://journals.plos.org/plosone/s/figures-->--> -->-->7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. ?>

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: No

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: No

Reviewer #2: No

**********

Reviewer #1: Manuscript: “Chemical characterization, antimicrobial, and antioxidant potentials of Juniperus phoeniceae wood tar”. Manuscript: “Chemical characterization, antimicrobial, and antioxidant potentials of Juniperus phoeniceae wood tar”. Manuscript: “Chemical characterization, antimicrobial, and antioxidant potentials of Juniperus phoeniceae wood tar”. Manuscript: “Chemical characterization, antimicrobial, and antioxidant potentials of Juniperus phoeniceae wood tar”.

The manuscript provides general information on the antibacterial and antioxidant activities of Juniperus phoenicea wood tar (JPWT), supported by qualitative and quantitative phytochemical analyses. However, it requires thorough English language revision and addressing of the following major issues:

Title

Correct "Juniperus phoeniceae" to “Juniperus phoenicea”. Please go throughout the entire manuscript.

Abstract

Correct "Juniperus phoeniceae" to “Juniperus phoenicea L.” in the first citation.

Rewrite "confirming its free radical-scavenging capability" to "confirming its antioxidant activity." Note that "radical-scavenging capability" is appropriate only when using radicals such as DPPH.

Materials and Methods

Rewrite the sentence "Voucher specimen of JP is deposited in the Herbarium (RAB114890) of the Scientific Institute of Rabat (Morocco) (Branches were examined for integrity and absence of dust and insect contamination)" for clarity and completeness.

Rename section "2.3. Preliminary phytochemical tests" to "2.3. Qualitative phytochemical tests."

Section 2.3.1: Avoid starting sentences with numbers.

Rewrite "After adding 2 mL of distilled water was added to 2 mL ethanolic solution of JPWT" for grammatical accuracy.

Correct "2.4.2. Flavonoid" to "2.4.2. Flavonoids."

Correct "2.4.3. Tannin" to "2.4.3. Tannins."

Correct "2.5.1. 2,2-Diphenyl-1-picrylhydrazylradical assay (DPPH)" to "2.5.1. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical assay."

Correct "Tests were carried out in triplicate using ascorbic acid and BHT has positive control" to "Tests were carried out in triplicate using ascorbic acid and BHT as positive controls."

Use consistent nomenclature throughout (e.g., J. phoeniceae or JPWT instead of "wood cedar" in section 2.5.1).

Specify the tested microorganisms in the sentence: "A suspension of the tested microorganism (0.5 mL of 106 cells/mL) was spread on nutrient agar."

Define abbreviations in the sentence: "Positive controls were prepared using the CN and IPM antibiotics."

Section 2.7. GC-MS analysis: Clarify how phytocompounds were identified.

Consider switching to HPLC-MS, which is more suitable for polyphenol, alkaloid, and flavonoid-rich extracts.

Define BSTFA.

Results

Correct all "Tableau X" to "Table X" (e.g., Table 1, Table 2… Table 6).

Use decimal points (.) consistently in values for Tables 2 and 3.

In Table 3, specify units for IC50

Section 3.4. GC-MS analysis: Avoid detailing retention times (RT) of identified compounds.

Correct "3.5. Antibacterial stains" to "3.5. Antibacterial activity."

Please insert the sentence "The antibacterial activity of JPWT was tested against both Gram-positive and Gram-negative bacteria at concentrations of 25 mg/mL and 50 mg/mL" in the Materials and Methods section.

Italicize scientific names (e.g., Staphylococcus aureus).

Discussion

Remove "Firstly,".

Rewrite "Phytochemical screening revealed the presence of alkaloids, tannins, phenols, and flavonoids (Table 1). Quantification of total phenolics, tannins, and flavonoids (Table 2) by UV-Visible spectroscopy demonstrated that JPWT is rich in these compound", to include in-depth literature-based discussion specific to J. phoeniceae.

Rewrite Table 5 title to "Inhibition zone diameter (mm) of Juniperus phoenicea wood tar and positive controls (antibiotics) against selected bacteria."

Report values in Table 5 as means of three replicates ± standard deviation, with appropriate statistical analysis.

Conclusions

Correct "Collectively, these results position JPWT as a valuable reservoir of bioactive natural products with considerable pharmaceutical and therapeutic promise" for grammatical accuracy and precision.

References

Complete the reference : El Jemli M. "Contribution to the ethnobotanical, toxicological, pharmacological and phytochemical study of four Moroccan Cupressaceae: Juniperus thurifera L., Juniperus oxycedrus L., Juniperus phoenicea L. and Tetraclinis articulata L." (Provide full details: thesis/degree, institution, year, etc., 2020).

Please recheck the whole reference list.

Reviewer #2: Submission ID: PONE-D-25-64294 Submission ID: PONE-D-25-64294 Submission ID: PONE-D-25-64294 Submission ID: PONE-D-25-64294

Journal: PLOS ONE

Dear authors,

Your manuscript entitled “Chemical Characterization, antimicrobial, and antioxidant potentials of Juniperus phoeniceae wood tar” has been reviewed. The topic of your manuscript is very interesting, you are following the right scientific path for writing your manuscript, and the manuscript is well organised and presents important information for the scientific field. However, the manuscript needs some improvements. Therefore, I would like to make some comments, recommendations about the revised manuscript:

• The objective of your research should be discussed in detail in the last paragraph of the introduction.

• What is the importance of adding a Molecular Docking section? Normally, the in-silico study should be carried out before starting the study.

• What is the added value of Molecular Docking for your study?

• The references cited in the Molecular Docking section are not compatible with the contents. Please check these references.

• Add a section for statistical analysis and add the results of the statistical analysis.

• The Discussion section requires a recent reference in the relevant fields and should show the socio-economic importance of your results in relation to those in the literature.

• For the conclusion, present the most important results, the socio-economic importance of the results obtained, as well as recommendations and prospects for your research.

**********

what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->

Reviewer #1: No

Reviewer #2: Yes: Azeddin EL BARNOSSIAzeddin EL BARNOSSIAzeddin EL BARNOSSIAzeddin EL BARNOSSI

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

Attachment

Submitted filename: plos.docx

pone.0345923.s001.docx (14.9KB, docx)
PLoS One. 2026 Apr 1;21(4):e0345923. doi: 10.1371/journal.pone.0345923.r002

Author response to Decision Letter 1


21 Jan 2026

The authors sincerely thank the editor and the reviewers for their valuable time, consideration, and suggestions.

Attachment

Submitted filename: Commentaires des reviewers de plos one 01.docx

pone.0345923.s003.docx (27.5KB, docx)

Decision Letter 1

Marcello Iriti

9 Feb 2026

Dear Dr. Tina,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 26 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols....

We look forward to receiving your revised manuscript.

Kind regards,

Marcello Iriti, Ph.D.

Academic Editor

PLOS One

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: No

Reviewer #2: Yes

**********

Reviewer #1: The authors have addressed most of the previous comments, but some points require further revision and clarification. Thorough English language revision is still needed throughout the manuscript.

Reference(s) is needed for this statement: "Among its derivatives, Juniperus phoeniceae wood tar (JPWT), obtained by the destructive distillation of JP wood, is traditionally used for skin ailments and infections."

Correct "Juniperus phoeniceae” in the whole document.

Revise references for qualitative phytochemical tests, ensuring the use of relevant references and correct numbering/formatting according to journal instructions.

Specify the amount of each antibiotic/disc.

State exactly the number of replicates in the Statistical analysis section.

Avoid starting sentences with numbers.

Provide the source/references for the MRSA, ESBL-EC, and CREC strains used in this study, and complete the references for ATCC strains as well.

Revise the chemical composition table, as the percentage areas sum to more than 100%. Clarify how these percentages were calculated and how identification was performed. Add the chromatogram if applicable.

Please include the statistical significance in the tables 3 & 5, rather than in the footnote for greater clarity.

Revise the sequence and order of headings (eg. chemical composition, antioxidant, antibacterial sections) to ensure a logical flow.

Reviewer #2: Manuscript Number: PONE-D-25-64294R1

Journal: PLOS One

Dear authors,

With these significant revisions, I consider the article suitable for publication.

**********

what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->

Reviewer #1: No

Reviewer #2: Yes: Azeddin EL BARNOSSIAzeddin EL BARNOSSIAzeddin EL BARNOSSIAzeddin EL BARNOSSI

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Apr 1;21(4):e0345923. doi: 10.1371/journal.pone.0345923.r004

Author response to Decision Letter 2


11 Mar 2026

The authors sincerely thank the editor and the reviewers for their valuable time, consideration, and suggestions. The constructive comments have significantly enhanced the overall quality of the manuscript. We trust that we have adequately addressed your inquiries and concerns

Attachment

Submitted filename: Plos one aswers revision 2.docx

pone.0345923.s004.docx (17.1KB, docx)

Decision Letter 2

Marcello Iriti

13 Mar 2026

Chemical Characterization, antimicrobial, and antioxidant potentials of Juniperus phoenicea wood tar

PONE-D-25-64294R2

Dear Dr. Tina,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support....

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Marcello Iriti, Ph.D.

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Reviewer #1: Dear authors,

The manuscript has been improved and is worthy of acceptance for publication.

**********

what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->

Reviewer #1: No

**********

Acceptance letter

Marcello Iriti

PONE-D-25-64294R2

PLOS One

Dear Dr. Tina,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Marcello Iriti

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: plos.docx

    pone.0345923.s001.docx (14.9KB, docx)
    Attachment

    Submitted filename: Commentaires des reviewers de plos one 01.docx

    pone.0345923.s003.docx (27.5KB, docx)
    Attachment

    Submitted filename: Plos one aswers revision 2.docx

    pone.0345923.s004.docx (17.1KB, docx)

    Data Availability Statement

    Data are available from the: https://github.com/khibech/Juniperus-phoenicea-.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES